This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Agilent Technologies, Inc., Biotek Instruments, Inc. Active years: 2021-2026.
Company Filing History:
Years Active: 2021-2026
Title: **The Innovative Journey of Brad Larson: A Pioneer in 3D Cell Washing Technology**
Introduction
Brad Larson, an accomplished inventor based in South Burlington, Vermont, has made significant contributions to the field of biotechnology with his innovative inventions. With a total of two patents to his name, his work focuses on enhancing the processes involved in working with three-dimensional (3D) cell cultures.
Latest Patents
One of Larson's prominent patents is the **3D Cell Washer**, an autoclaving microplate washing system specifically designed for cells and non-adhering 3D cell cultures. This advanced system includes a dispensing pump, an aspirating peristaltic pump, and a processor capable of executing a cleaning control program. The program independently regulates the dispensing and aspirating pumps to manage the flow rates of solutions and waste fluid. This innovative design allows for gentle washing of cells, making the process more efficient and effective.
Career Highlights
Larson has built a remarkable career in the biotechnology sector, having worked with prestigious companies. He has been affiliated with **Biotek Instruments, Inc.** and **Agilent Technologies, Inc.**, where he contributed to research and development efforts aimed at revolutionizing cell culture techniques.
Collaborations
Throughout his career, Brad Larson has collaborated with talented professionals, including Christopher Many and Byron Smith. These partnerships have fostered a creative environment, leading to the development of groundbreaking technologies in the field.
Conclusion
Brad Larson's contributions through his patents and collaborations highlight his inventiveness and commitment to advancing biotechnology. His work, particularly in the realm of 3D cell cultures, has significant implications for research and clinical applications, paving the way for future innovations in cell washing technologies.